Convergent solid-phase synthesis of hirudin

被引:11
作者
Goulas, S [1 ]
Gatos, D [1 ]
Barlos, K [1 ]
机构
[1] Univ Patras, Dept Chem, GR-26010 Patras, Greece
关键词
hirudin; 2-chlorotrityl resin; convergent synthesis; protected peptide fragments; solid-phase fragment condensation; oxidative folding; solid-phase peptide synthesis;
D O I
10.1002/psc.691
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hirudin variant 1 (HV1), a small protein consisting of 65 amino acids and three disulfide bonds, was synthesized by using Fmoc-based convergent methods on 2-chlorotrityl resin (CLTR). The linear sequence was assembled by the sequential condensation of 7 protected fragments, on the resin-bound 55-65 fragment. The conditions of fragment assembly were carefully studied to determine the most efficient synthetic protocol. Crude reduced [Cys(16.28)(Acm)]-HV1 thus obtained was easily purified to homogeneity by RP-HPLC. Disuffide bridges were successfully formed by a two-step procedure, involving an oxidative folding step to form Cys(6)-Cys(14) and Cys(22)-Cys(39) linkages, followed by iodine oxidation to form the Cys(16)-Cys(28) bond. The correct disuffide bond alignment was established by peptide mapping using Staphylococcus aureus V8 protease at pH 4.5. Copyright (c) 2005 European Peptide Society and John Wiley & Sons, Ltd.
引用
收藏
页码:116 / 123
页数:8
相关论文
共 15 条
[11]   UNTERSUCHUNGEN UBER HIRUDIN [J].
MARKWARDT, F .
NATURWISSENSCHAFTEN, 1955, 42 (19) :537-538
[12]   THE DEVELOPMENT OF HIRUDIN AS AN ANTITHROMBOTIC DRUG [J].
MARKWARDT, F .
THROMBOSIS RESEARCH, 1994, 74 (01) :1-23
[13]   Current status of the anticoagulant hirudin: its biotechnological production and clinical practice [J].
Sohn, JH ;
Kang, HA ;
Rao, KJ ;
Kim, CH ;
Choi, ES ;
Chung, BH ;
Rhee, SK .
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2001, 57 (5-6) :606-613
[14]   KINETICS OF THE INHIBITION OF THROMBIN BY HIRUDIN [J].
STONE, SR ;
HOFSTEENGE, J .
BIOCHEMISTRY, 1986, 25 (16) :4622-4628
[15]   DEVELOPMENT OF RECOMBINANT HIRUDIN AS A THERAPEUTIC ANTICOAGULANT AND ANTITHROMBOTIC AGENT - SOME OBJECTIVE CONSIDERATIONS [J].
WALENGA, JM ;
PIFARRE, R ;
HOPPENSTEADT, DA ;
FAREED, J .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1989, 15 (03) :316-333